2448-5691
2448-5691
S2448-56912025000200108
10.22201/ceiich.24485691e.2025.35.69850
Mexico
Mexico
00
12
2025
00
12
2025
18
35
[
2020
12
11
11
]
[
2024
7
3
3
1336-61
]
[
2020
10
3
3
231-40
]
[
2011
32
7
7
958-68
]
[
2018
553
1-2
1-2
441-53
]
[
2022
14
4
4
]
[
2021
11
5
5
]
[
2024
57
8
8
1098-110
]
[
2018
271
55-9
]
[
2011
]
[
2020
]
[
2015
485
1-2
1-2
215-28
]
[
2016
23
9
9
3639-52
]
[
2015
495
1
1
374-84
]
[
2019
2019
2019
]
[
2016
104
19-29
]
[
Clinical Trials
2024
]
[
2019
48
2
2
260-313
]
[
2012
14
2
2
244-51
]
[
2022
23
4
4
]
[
2014
40
4
4
477-87
]
[
2014
103
4
4
1050-63
]
[
2022
12
7
7
1616-39
]
[
2015
22
6
6
675-90
]
[
FDA
2019
]
[
2022
47-131
]
[
2019
557
febrero
febrero
124-34
]
[
2024
14
10
10
1-17
]
[
2022
182
]
[
2022
]
[
2022
7
]
[
2018
114
74-83
]
[
2024
25
1
1
]
[
2013
9
1
1
26-39
]
[
2024
45
5
5
969-79
]
[
2022
14
9
9
]
[
2023
632
]
[
2022
68
febrero
febrero
]
[
2014
114
365-74
]
[
2019
24
16
16
1-13
]
[
2011
1
4
4
208-19
]
[
2000
45
1
1
89-121
]
[
2024
]
[
2019
142
marzo
marzo
91-101
]
[
2016
13
11
11
1503-12
]
[
2017
533
2
2
335-45
]
[
2022
8
1
1
]
[
2024
]
[
2012
436
1-2
1-2
58-65
]
[
2021
18
3
3
315-32
]
[
2013
453
1
1
215-24
]
[
2020
18
4
4
]
[
2021
5
1
1
52-8
]
[
2019
561
197-205
]
[
2010
39
4
4
224-32
]
[
2021
143
]
[
2018
535
1-2
1-2
371-8
]
[
2023
354
465-88
]
[
2022
14
8
8
]
[
2020
12
4
4
]
[
2024
4
1
1
5-30
]
[
2025
]
[
2017
421-44
]
[
2022
15
9
9
]
[
2021
]
[
2023
18
2
2
525-37
]
[
2018
531
253-60
]
[
2013
180
abril
abril
89-94
]
[
2016
57
3
3
97-109
]
[
2020
]
[
2023
28
12
Landmark
12
]
[
2013
450
1-2
1-2
79-86
]
[
2025
17
1
1
]
[
2008
362
1
1
2-9
]
[
2019
142
marzo
marzo
16-34
]
[
2018
130
236-46
]
[
2013
65
1
1
315-499
]
[
2021
]